Chandra Bhagat Pharma Share Price

Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name Chandra Bhagat Pharma Private Limited at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to Chandra Bhagat Pharma Limited on March 20, 2019.On April 1, 2003, the Company acquired a going concern business of M/s. Chandra Bhagat Corporation, partnership firm and consequently, the Company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation upon the acquisition. Thereafter, the Promoter Mr. Hemant Bhagat continued the business on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics, Antineoplastic, Cardiovascular, Hormones etc. and set up the Companys marketing force to wider the product portfolio. Subsequently in 2004, the Promoters, Mr. Pranav Bhagat son of Mr. Hemant Bhagat, joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market.The Company is engaged in the business of marketing pharmaceutical critical care health care products. For which it obtained necessary approvals from FDA for getting the formulations manufacture from contract manufacturers. At present, the Company has a wide range of products portfolio of pharmaceutical formulation including IV IM range Injections, few tablets to cater the Domestic Export Market. It has established presence in major therapeutic categories for formulations such as Anticancer (Oncology), Antibiotics, Anaesthesia, Hormones, Orthopaedic, Cardiac, Cardiovascular, Antifungal, Antiviral, Paediatrics, Cardiology, Nephrology, Neurology etc. It is engaged in promoting and marketing of Active Pharmaceuticals Ingredients (APIs) in India.The Company launched the IPO by issuing 20,00,000 equity shares of Rs 10 and raised Rs 10.2 crores through fresh issue on 6 February, 2020.